Literature DB >> 7976441

Recovery from depression after electroconvulsive therapy is accompanied by evidence of increased tetrahydrobiopterin-dependent hydroxylation.

D N Anderson1, A M Wilkinson, M T Abou-Saleh, J A Blair.   

Abstract

Serum phenylalanine and tyrosine levels were measured in 26 patients with severe depression before and after receiving electroconvulsive therapy. The phenylalanine:tyrosine [P:T] ratio declined significantly for those responding to treatment but not for nonresponders. These findings are discussed in relation to tetrahydrobiopterin, the essential cofactor for the formation of noradrenaline, dopamine and serotonin and the hydroxylation of phenylalanine to tyrosine.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7976441     DOI: 10.1111/j.1600-0447.1994.tb01547.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  11 in total

1.  Reciprocal moderation by Toxoplasma gondii seropositivity and blood phenylalanine - tyrosine ratio of their associations with trait aggression.

Authors:  Ashwin Jacob Mathai; Christopher A Lowry; Thomas B Cook; Lisa A Brenner; Lena Brundin; Maureen W Groer; Xiaoqing Peng; Ina Giegling; Annette M Hartmann; Bettina Konte; Marion Friedl; Dietmar Fuchs; Dan Rujescu; Teodor T Postolache
Journal:  Pteridines       Date:  2016-10-21       Impact factor: 0.581

2.  Serum Phenylalanine, Tyrosine, and their Ratio in Acute Ischemic Stroke: on the Trail of a Biomarker?

Authors:  Heidi Ormstad; Robert Verkerk; Leiv Sandvik
Journal:  J Mol Neurosci       Date:  2015-09-30       Impact factor: 3.444

3.  Treatment of patients with geriatric depression with repetitive transcranial magnetic stimulation.

Authors:  F Leblhuber; K Steiner; Dietmar Fuchs
Journal:  J Neural Transm (Vienna)       Date:  2019-06-27       Impact factor: 3.575

4.  Metabolomics Study of Resina Draconis on Myocardial Ischemia Rats Using Ultraperformance Liquid Chromatography/Quadrupole Time-of-Flight Mass Spectrometry Combined with Pattern Recognition Methods and Metabolic Pathway Analysis.

Authors:  Yunpeng Qi; Haiwei Gu; Yunlong Song; Xin Dong; Aijun Liu; Ziyang Lou; Guorong Fan; Yifeng Chai
Journal:  Evid Based Complement Alternat Med       Date:  2013-05-26       Impact factor: 2.629

Review 5.  Disturbed Amino Acid Metabolism in HIV: Association with Neuropsychiatric Symptoms.

Authors:  Johanna M Gostner; Kathrin Becker; Katharina Kurz; Dietmar Fuchs
Journal:  Front Psychiatry       Date:  2015-07-14       Impact factor: 4.157

6.  Immune activation and inflammation in patients with cardiovascular disease are associated with higher phenylalanine to tyrosine ratios: the ludwigshafen risk and cardiovascular health study.

Authors:  Christian Murr; Tanja B Grammer; Andreas Meinitzer; Marcus E Kleber; Winfried März; Dietmar Fuchs
Journal:  J Amino Acids       Date:  2014-02-10

Review 7.  Diet Versus Exercise in Weight Loss and Maintenance: Focus on Tryptophan.

Authors:  Barbara Strasser; Dietmar Fuchs
Journal:  Int J Tryptophan Res       Date:  2016-05-10

8.  Blood Levels of Monoamine Precursors and Smoking in Patients with Schizophrenia.

Authors:  Ashwin Jacob Mathai; Jyoti Kanwar; Olaoluwa Okusaga; Dietmar Fuchs; Christopher A Lowry; Xiaoqing Peng; Ina Giegling; Annette M Hartmann; Bettina Konte; Marion Friedl; Claudia Gragnoli; Gloria M Reeves; Maureen W Groer; Richard N Rosenthal; Dan Rujescu; Teodor T Postolache
Journal:  Front Public Health       Date:  2016-08-30

Review 9.  Brain Kynurenine and BH4 Pathways: Relevance to the Pathophysiology and Treatment of Inflammation-Driven Depressive Symptoms.

Authors:  Sylvie Vancassel; Lucile Capuron; Nathalie Castanon
Journal:  Front Neurosci       Date:  2018-07-24       Impact factor: 4.677

10.  Repetitive transcranial magnetic stimulation in the treatment of resistant depression: changes of specific neurotransmitter precursor amino acids.

Authors:  F Leblhuber; S Geisler; D Ehrlich; K Steiner; G Reibnegger; Dietmar Fuchs; K Kurz
Journal:  J Neural Transm (Vienna)       Date:  2021-07-09       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.